Home › NDC Lookup › RxCUI directory › RxCUI 2046148

4 ML bevacizumab-awwb 25 MG/ML Injection — RxCUI 2046148

RxNorm drug concept · Semantic clinical drug
RxCUI 2046148 Semantic clinical drug · SCD ● Current RxNorm concept 2 FDA products 4 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2046148
Official name4 ML bevacizumab-awwb 25 MG/ML Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asbevacizumab-awwb 100 MG per 4 ML Injection; bevacizumab-awwb 100 MG in 4 ML Injection
FDA products mapped2
Package NDCs mapped4
Reported Medicaid activity (SDUD)24,746 prescriptions · 47 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Bevacizumab Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Bevacizumab works by blocking a protein called VEGF, which tumors use to grow new blood vessels. Without that blood supply, the tumor has a harder time getting the nutrients it nee...
  • What exactly does bevacizumab do, and why am I getting it?
  • Bevacizumab is given through an IV — directly into a vein — by a nurse or infusion specialist at a clinic or cancer center. Your first infusion runs slowly over 90 minutes so the t...
  • How is it given, and how long does each infusion take?
📖 Read our full Bevacizumab Injection guide →

🕸️ Concept Web — How 4 ML bevacizumab-awwb 25 MG/ML Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 4 ML bevacizumab-awwb 25 MG/ML Injection RxCUI 2046148

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Bevacizumab 253337
    • Bevacizumab-awwb 2046138
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Mvasi 2046141
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Bevacizumab Injection 1657065
    • Bevacizumab-awwb Injection 2647183
    • Bevacizumab Injectable Product 1161185
    • Bevacizumab-awwb Injectable Product 2660526
    • Bevacizumab Injection [Mvasi] 2046143
    • Bevacizumab-awwb Injection [Mvasi] 2658024
    • Mvasi Injectable Product 2046144
    • Injection 1649574
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Bevacizumab-awwb 25 MG/ML SCDC · 2046139
  • Bevacizumab Injection SCDF · 1657065
  • Bevacizumab-awwb Injection SCDFP · 2647183
  • Bevacizumab Injectable Product SCDG · 1161185
  • Bevacizumab-awwb Injectable Product SCDGP · 2660526

Brand-Name Concepts

  • 4 ML bevacizumab-awwb 25 MG/ML Injection [Mvasi] SBD · 2046149
  • Bevacizumab-awwb 25 MG/ML [Mvasi] SBDC · 2046142
  • Bevacizumab Injection [Mvasi] SBDF · 2046143
  • Bevacizumab-awwb Injection [Mvasi] SBDFP · 2658024
  • Mvasi Injectable Product SBDG · 2046144
  • Mvasi BN · 2046141

📦 FDA Products & Package NDCs

2 products · 4 package NDCs
4 package NDCs map to RxCUI 2046148 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
55513-0206-01 1 VIAL in 1 CARTON (55513-206-01) / 4 mL in 1 VIAL MVASI Amgen, Inc 2018-06-01
55513-0206-21 1 VIAL in 1 CARTON (55513-206-21) / 4 mL in 1 VIAL MVASI Amgen, Inc 2025-06-27
55513-0207-01 1 VIAL in 1 CARTON (55513-207-01) / 16 mL in 1 VIAL MVASI Amgen, Inc 2018-06-01
55513-0207-21 1 VIAL in 1 CARTON (55513-207-21) / 16 mL in 1 VIAL MVASI Amgen, Inc 2025-06-27
Observed labelers: Amgen, Inc (4) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
CodeDescriptorMapped packagesSources
Q5107 Inj mvasi 10 mg 4 CMS
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.